Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Labenz

Showing results (91-100 of 144) with videos related to

Pageof 15
Sort By:
Hepatology Communications|April 12, 2022
Effect of hepatic steatosis and associated metabolic comorbidities on health-related quality of life in people living with HIVMaurice Michel, Christian Labenz, Malena Anders, et al.
Alimentary Pharmacology & Therapeutics|June 30, 2020
Association between diabetes mellitus and hepatic encephalopathy in patients with cirrhosisChristian Labenz, Michael Nagel, Wolfgang M Kremer, et al.
Journal of Cachexia, Sarcopenia and Muscle|December 9, 2021
Sonographic assessment of low muscle quantity identifies mortality risk during COVID-19: a prospective single-centre studyWolfgang M Kremer, Christian Labenz, Robert Kuchen, et al.
Scientific Reports|October 16, 2021
Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosisMaurice Michel, Cornelius Hess, Leonard Kaps, et al.
Clinical and Translational Gastroenterology|August 9, 2020
Validation of the Clinical Frailty Scale for the Prediction of Mortality in Patients With Liver CirrhosisWolfgang M Kremer, Michael Nagel, Michael Reuter, et al.
European Journal of Internal Medicine|September 3, 2020
Impact of non-selective ß-blockers on hepatic encephalopathy in patients with liver cirrhosisChristian Labenz, Michael Nagel, Gerrit Toenges, et al.
Hepatology Communications|October 30, 2023
Development and evaluation of a virtual reality driving test for patients with cirrhosisSimon J Gairing, Eva M Schleicher, Leonard Kaps, et al.
Inflammatory Intestinal Diseases|June 21, 2018
Risk Factors for the Development of Fistulae and Stenoses in Crohn Disease Patients in the Swiss Inflammatory Bowel Disease CohortJonas Zeitz, Nicolas Fournier, Christian Labenz, et al.
Hepatology Communications|January 15, 2022
Evaluation of IL-6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver CirrhosisSimon Johannes Gairing, Julian Anders, Leonard Kaps, et al.
Scientific Reports|December 6, 2022
Health literacy in gastrointestinal diseases: a comparative analysis between patients with liver cirrhosis, inflammatory bowel disease and gastrointestinal cancerLeonard Kaps, Lea Omogbehin, Katharina Hildebrand, et al.
Pageof 15

Showing results (91-100 of 144) with videos related to

Sort By:
Pageof 15
Hepatology Communications|April 12, 2022
Effect of hepatic steatosis and associated metabolic comorbidities on health-related quality of life in people living with HIVMaurice Michel, Christian Labenz, Malena Anders, et al.
Alimentary Pharmacology & Therapeutics|June 30, 2020
Association between diabetes mellitus and hepatic encephalopathy in patients with cirrhosisChristian Labenz, Michael Nagel, Wolfgang M Kremer, et al.
Journal of Cachexia, Sarcopenia and Muscle|December 9, 2021
Sonographic assessment of low muscle quantity identifies mortality risk during COVID-19: a prospective single-centre studyWolfgang M Kremer, Christian Labenz, Robert Kuchen, et al.
Scientific Reports|October 16, 2021
Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosisMaurice Michel, Cornelius Hess, Leonard Kaps, et al.
Clinical and Translational Gastroenterology|August 9, 2020
Validation of the Clinical Frailty Scale for the Prediction of Mortality in Patients With Liver CirrhosisWolfgang M Kremer, Michael Nagel, Michael Reuter, et al.
European Journal of Internal Medicine|September 3, 2020
Impact of non-selective ß-blockers on hepatic encephalopathy in patients with liver cirrhosisChristian Labenz, Michael Nagel, Gerrit Toenges, et al.
Hepatology Communications|October 30, 2023
Development and evaluation of a virtual reality driving test for patients with cirrhosisSimon J Gairing, Eva M Schleicher, Leonard Kaps, et al.
Inflammatory Intestinal Diseases|June 21, 2018
Risk Factors for the Development of Fistulae and Stenoses in Crohn Disease Patients in the Swiss Inflammatory Bowel Disease CohortJonas Zeitz, Nicolas Fournier, Christian Labenz, et al.
Hepatology Communications|January 15, 2022
Evaluation of IL-6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver CirrhosisSimon Johannes Gairing, Julian Anders, Leonard Kaps, et al.
Scientific Reports|December 6, 2022
Health literacy in gastrointestinal diseases: a comparative analysis between patients with liver cirrhosis, inflammatory bowel disease and gastrointestinal cancerLeonard Kaps, Lea Omogbehin, Katharina Hildebrand, et al.
Pageof 15